These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38028865)

  • 21. Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome.
    Iselin C; Chang YT; Schlaepfer T; Fassnacht C; Dimitriou F; Nägeli M; Pascolo S; Hoetzenecker W; Bobrowicz M; Guenova E
    Oncoimmunology; 2021 Jan; 10(1):1873530. PubMed ID: 33643690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T
    Peacock A; Dehle F; Mesa Zapata OA; Prince HM; Gennari F; Taylor C
    Value Health; 2022 Jun; 25(6):965-974. PubMed ID: 35667784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
    Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
    Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix-dependent absorption of 8-methoxypsoralen in extracorporeal photopheresis.
    Hähnel V; Weber I; Tuemmler S; Graf B; Gruber M; Burkhardt R; Ahrens N
    Photochem Photobiol Sci; 2020 Aug; 19(8):1099-1103. PubMed ID: 32638713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis.
    George JF; Gooden CW; Guo L; Kirklin JK
    J Heart Lung Transplant; 2008 Jun; 27(6):616-22. PubMed ID: 18503960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
    Laulhé M; Lefebvre S; Le Broc-Ryckewaert D; Pierre M; Ferry A; Delorme B
    PLoS One; 2019; 14(3):e0212835. PubMed ID: 30822323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal photopheresis: a review.
    Oliven A; Shechter Y
    Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Network Analysis of Effect of Light-Dark Time Ratio on the Gene Expression Profile of Mouse Skin.
    Arjmand B; Hamzeloo-Moghadam M; Razzaghi Z; Rostami Nejad M; Zamanian Azodi M; Khodadoost M; Rezaei Tavirani M; Rezaei Tavirani M; Ahmadzadeh A
    J Lasers Med Sci; 2022; 13():e68. PubMed ID: 37041769
    [No Abstract]   [Full Text] [Related]  

  • 32. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The North American experience with photopheresis.
    Zic JA; Miller JL; Stricklin GP; King LE
    Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes.
    Bladon J; Taylor PC
    Br J Dermatol; 2002 Jan; 146(1):59-68. PubMed ID: 11841367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study.
    Christensen E; Foss OA; Quist-Paulsen P; Staur I; Pettersen F; Holien T; Juzenas P; Peng Q
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American council on ECP (ACE): Why now?
    Edelson R; Wu Y; Schneiderman J
    J Clin Apher; 2018 Aug; 33(4):464-468. PubMed ID: 29575114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
    Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
    Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
    Bladon J; Taylor PC
    Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.